Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Griesinger

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
Reproductive Biomedicine Online|January 27, 2020
Fully human glyco-optimized recombinant FSH (follitropin epsilon) - a randomized, comparator-controlled phase II clinical trialGeorg Griesinger, Bruno Dietrich, Lars Stöckl, et al.
Fertility and Sterility|February 28, 2006
Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocolGeorg Griesinger, Anja Dawson, Askan Schultze-Mosgau, et al.
Reproductive Biomedicine Online|January 14, 2011
Intensified ovarian stimulation in a GnRH antagonist protocol with agonist triggering: a prospective, clinical feasibility studyGeorg Griesinger, Henriette Berndt, Laura Schultz, et al.
Fertility and Sterility|October 3, 2013
Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trialsGeorg Griesinger, Bernadette Mannaerts, Claus Yding Andersen, et al.
Reproductive Biomedicine Online|May 15, 2016
Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysisGeorg Griesinger, Robert Boostanfar, Keith Gordon, et al.
Reproductive Biomedicine Online|June 27, 2026
Response to: Clarifying Molecular Specificity and Outcome Definitions in Progestogen Route Meta-AnalysisGeorg Griesinger, Qian Wang, Elena Labarta, et al.
Expert Opinion on Investigational Drugs|September 8, 2005
New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonistsAskan Schultze-Mosgau, Georg Griesinger, Christopher Altgassen, et al.
Reproductive Biomedicine Online|November 3, 2018
The use of intracytoplasmic sperm injection is associated with a shift in the secondary sex ratioChristoph Cirkel, Inke R König, Askan Schultze-Mosgau, et al.
Fertility and Sterility|December 3, 2013
Reply of the authorsGeorg Griesinger, Bernadette Mannaerts, Claus Yding Andersen, et al.
Archives of Gynecology and Obstetrics|December 13, 2017
What is the net effect of introducing vitrification for cryopreservation of surplus 2PN oocytes in an IVF program?Manja Golakov, Marion Depenbusch, Askan Schultze-Mosgau, et al.
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Reproductive Biomedicine Online|January 27, 2020
Fully human glyco-optimized recombinant FSH (follitropin epsilon) - a randomized, comparator-controlled phase II clinical trialGeorg Griesinger, Bruno Dietrich, Lars Stöckl, et al.
Fertility and Sterility|February 28, 2006
Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocolGeorg Griesinger, Anja Dawson, Askan Schultze-Mosgau, et al.
Reproductive Biomedicine Online|January 14, 2011
Intensified ovarian stimulation in a GnRH antagonist protocol with agonist triggering: a prospective, clinical feasibility studyGeorg Griesinger, Henriette Berndt, Laura Schultz, et al.
Fertility and Sterility|October 3, 2013
Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trialsGeorg Griesinger, Bernadette Mannaerts, Claus Yding Andersen, et al.
Reproductive Biomedicine Online|May 15, 2016
Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysisGeorg Griesinger, Robert Boostanfar, Keith Gordon, et al.
Reproductive Biomedicine Online|June 27, 2026
Response to: Clarifying Molecular Specificity and Outcome Definitions in Progestogen Route Meta-AnalysisGeorg Griesinger, Qian Wang, Elena Labarta, et al.
Expert Opinion on Investigational Drugs|September 8, 2005
New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonistsAskan Schultze-Mosgau, Georg Griesinger, Christopher Altgassen, et al.
Reproductive Biomedicine Online|November 3, 2018
The use of intracytoplasmic sperm injection is associated with a shift in the secondary sex ratioChristoph Cirkel, Inke R König, Askan Schultze-Mosgau, et al.
Fertility and Sterility|December 3, 2013
Reply of the authorsGeorg Griesinger, Bernadette Mannaerts, Claus Yding Andersen, et al.
Archives of Gynecology and Obstetrics|December 13, 2017
What is the net effect of introducing vitrification for cryopreservation of surplus 2PN oocytes in an IVF program?Manja Golakov, Marion Depenbusch, Askan Schultze-Mosgau, et al.
Pageof 12